King International Investment Limited, an investment holding company, provides genetic testing and health data analysis services in the People’s Republic of China and Hong Kong. The company operates through two segments, Healthcare Products and Services Business, and Money Lending Business. The company also engages in money lending activities. In addition, it provides corporate administrative and healthcare services. The company was formerly known as Life Healthcare Group Limited and changed its name to King International Investment Limited in December 2023. King International Investment Limited was incorporated in 2001 and is based in Central, Hong Kong.
Metrics to compare | 0928 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship0928PeersSector | |
---|---|---|---|---|
P/E Ratio | 13.9x | −0.3x | −0.5x | |
PEG Ratio | 0.09 | 0.02 | 0.00 | |
Price/Book | 0.6x | 0.6x | 2.6x | |
Price / LTM Sales | 0.9x | 1.1x | 3.3x | |
Upside (Analyst Target) | - | 0.0% | 43.4% | |
Fair Value Upside | Unlock | 6.4% | 7.1% | Unlock |